382 related articles for article (PubMed ID: 28340881)
21. Therapeutic use of mistletoe for CD30+ cutaneous lymphoproliferative disorder/lymphomatoid papulosis.
Seifert G; Tautz C; Seeger K; Henze G; Laengler A
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):558-60. PubMed ID: 17374000
[No Abstract] [Full Text] [Related]
22. Nodal anaplastic large-cell lymphoma ALK-1- with CD30+ cutaneous lymphoproliferation treated with mistletoe: spontaneous remission or treatment response?
Kameda G; Kempf W; Oschlies I; Michael K; Seifert G; Längler A
Klin Padiatr; 2011 Nov; 223(6):364-7. PubMed ID: 22052633
[TBL] [Abstract][Full Text] [Related]
23. Contribution of longitudinal follow up and clinical pathological correlation in the diagnosis CD30-positive skin infiltrates.
De Souza A; Carter JB; Harris NL; Ferry JA; Duncan LM
J Cutan Pathol; 2015 Jul; 42(7):452-8. PubMed ID: 25931140
[TBL] [Abstract][Full Text] [Related]
24. SATB1 Defines a Subtype of Cutaneous CD30
Sun J; Yi S; Qiu L; Fu W; Wang A; Liu F; Wang L; Wang T; Chen H; Wang L; Kadin ME; Tu P; Wang Y
J Invest Dermatol; 2018 Aug; 138(8):1795-1804. PubMed ID: 29510190
[TBL] [Abstract][Full Text] [Related]
25. An unusual case of lymphomatoid papulosis type E with extensive necrosis.
Pindado-Ortega C; Fonda-Pascual P; Buendía-Castaño D; Fernández-González P; Peña-Jaimes L; Carrillo-Gijón R
Indian J Dermatol Venereol Leprol; 2018; 84(4):515-517. PubMed ID: 29067932
[TBL] [Abstract][Full Text] [Related]
26. Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration.
Marschalkó M; Eros N; Holló P; Hársing J; Bottlik G; Bátai A; Csukly Z; Masszi T; Szentirmai Z; Fodor J; Kárpáti S; Matolcsy A; Csomor J
Am J Dermatopathol; 2010 Oct; 32(7):708-12. PubMed ID: 20644462
[TBL] [Abstract][Full Text] [Related]
27. Is it lymphoma or lymphomatoid papulosis?
Demierre MF; Goldberg LJ; Kadin ME; Koh HK
J Am Acad Dermatol; 1997 May; 36(5 Pt 1):765-72. PubMed ID: 9146539
[TBL] [Abstract][Full Text] [Related]
28. [Primary cutaneous anaplastic large cell lymphoma with systemic progression responding to low-dose methotrexate therapy].
Sumitani R; Harada T; Nakamura M; Mizuguchi M; Oura M; Sogabe K; Maruhashi T; Takahashi M; Fujii S; Nakamura S; Miki H; Kagawa K; Yada M; Matsudate Y; Uehara H; Abe M
Rinsho Ketsueki; 2022; 63(6):536-543. PubMed ID: 35831185
[TBL] [Abstract][Full Text] [Related]
29. Pediatric oral Epstein-Barr virus associated self-remitting CD30+ lymphoproliferative disorder: A distinct entity.
Schwartz Z; Bowe RB; Coleman M; Magro CM
Ann Diagn Pathol; 2018 Dec; 37():57-61. PubMed ID: 30292067
[TBL] [Abstract][Full Text] [Related]
30. Spectrum of CD30+ lymphoid proliferations in the eyelid lymphomatoid papulosis, cutaneous anaplastic large cell lymphoma, and anaplastic large cell lymphoma.
Sanka RK; Eagle RC; Wojno TH; Neufeld KR; Grossniklaus HE
Ophthalmology; 2010 Feb; 117(2):343-51. PubMed ID: 19969358
[TBL] [Abstract][Full Text] [Related]
31. [Neutrophil-rich, anaplastic CD30+ T cell lymphoma in conjunction with lymphomatoid papulosis].
Slotosch CM; Hörster S; Hertl M; Schultz E
Hautarzt; 2010 Jun; 61(6):511-3. PubMed ID: 19536511
[TBL] [Abstract][Full Text] [Related]
32. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.
Bekkenk MW; Geelen FA; van Voorst Vader PC; Heule F; Geerts ML; van Vloten WA; Meijer CJ; Willemze R
Blood; 2000 Jun; 95(12):3653-61. PubMed ID: 10845893
[TBL] [Abstract][Full Text] [Related]
33. Association of clinicopathological characteristics with secondary neoplastic lymphoproliferative disorders in patients with lymphomatoid papulosis.
Nikolaou V; Papadavid E; Ekonomidi A; Dalamaga M; Marinos L; Stratigos A; Papadaki T; Antoniou C
Leuk Lymphoma; 2015 May; 56(5):1303-7. PubMed ID: 25242096
[TBL] [Abstract][Full Text] [Related]
34. Novel use of 308-nm excimer laser to treat a primary cutaneous CD30+ lymphoproliferative nodule.
Meisenheimer JL
J Drugs Dermatol; 2007 Apr; 6(4):440-2. PubMed ID: 17668543
[TBL] [Abstract][Full Text] [Related]
35. [Lymphomatoid papulosis type C or transition to CD30+-T-cell lymphoma? A difficult differential diagnosis].
Plettenberg H; Neumann NJ; Ruzicka T; Megahed M
Hautarzt; 2003 Apr; 54(4):366-8. PubMed ID: 12669213
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous anaplastic large cell lymphoma.
Brown RA; Fernandez-Pol S; Kim J
J Cutan Pathol; 2017 Jun; 44(6):570-577. PubMed ID: 28342276
[TBL] [Abstract][Full Text] [Related]
37. Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders.
De Souza A; Tinguely M; Pfaltz M; Burghart DR; Kempf W
J Cutan Pathol; 2014 Dec; 41(12):901-6. PubMed ID: 25353265
[TBL] [Abstract][Full Text] [Related]
38. [Lymphomatoid papulosis in a 2 1/2-year-old boy].
Amann PM; Megahed M
Hautarzt; 2011 Nov; 62(11):807-9. PubMed ID: 22037883
[TBL] [Abstract][Full Text] [Related]
39. Lymphomatoid papulosis and anaplastic large cell lymphomas of the skin.
Drews R; Samel A; Kadin ME
Semin Cutan Med Surg; 2000 Jun; 19(2):109-17. PubMed ID: 10892712
[TBL] [Abstract][Full Text] [Related]
40. Histopathological aspects and differential diagnosis of CD8 positive lymphomatoid papulosis.
Marschalkó M; Gyöngyösi N; Noll J; Károlyi Z; Wikonkál N; Hársing J; Kuroli E; Csomor J; Matolcsy A; Sarolta K; Szepesi Á
J Cutan Pathol; 2016 Nov; 43(11):963-973. PubMed ID: 27461449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
